PDT Partners’s Biodesix BDSX Stock Holding History

PDT Partners’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-860	Closed	-$91K	–	938
2021 Q4	$91K	Sell	860 -309	-26%	-$40.4K	0.01%	827
2021 Q3	$192K	Buy	+1,169	New	+$222K	0.01%	698

Other funds holding BDSX

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

PDT Partners's BDSX Position: Q1 2022 in Review

PDT Partners sold out of Biodesix (BDSX) in Q1 2022, closing a stake of 860 shares — an estimated $91K sold.

PDT Partners first reported a position in BDSX in Q3 2021 and held it in 2 quarters. The position peaked at $192K in Q3 2021. 46 funds tracked by Wall St. Rank hold BDSX as of Q1 2022.

PDT Partners reported no remaining Biodesix position as of Q1 2022 after selling out during the quarter.
PDT Partners sold 860 Biodesix shares in Q1 2022, an estimated $91K.
PDT Partners first reported a position in Biodesix in Q3 2021 and held it in 2 quarters.
PDT Partners's Biodesix position peaked at $192K in Q3 2021.
46 funds tracked by Wall St. Rank held Biodesix as of Q1 2022.

Based on PDT Partners's 13F filing for Q1 2022, filed 16 May 2022.